MAPT and supranuclear palsy, progressive, 1: Phosphorylated-tau immunohistochemistry showed pathology consistent with PSP, but tau pathology was milder than in most cases of PSP (Fig. 1U–X) (Table), while there was marked pallido-nigro-luysial degeneration (8).